$7.34-17.2%Nov 13 close
Figures through September 30, 2026, from the 10-Q filed November 13, 2026
Company outlook: revenue of $87M to $93M for Fiscal year 2026 — down 17.8% on a year earlier ($109.4M)
Just reported
From OptimizeRx Corp's results release of November 13, 2026; its quarterly report has since been filed.
Actual
$21.6M
-17% y/y
+5.4% q/q
Guided
—
No guide given
Actual
$0.06
+50% y/y
Guided
—
No guide given
Actual
$2.7M
| Measure | 3 months toSep 30, 2026 | 3 months toSep 30, 2025 | Change |
|---|---|---|---|
| Total Revenue | $21.6M | $26.1M | -17.08% |
| Profit | $1.2M | $779K | +53.40% |
| Profit per share | $0.06 | $0.04 | +50.00% |
| Free Cash Flow | $4.7M | $3.2M | +47.99% |
These are single quarters, not a trailing year — the figures elsewhere on this site cover twelve months and will be much larger. A seasonal business swings a long way between the two: ServiceNow earns $2.0B of free cash flow in its December quarter and $0.5B in its June one.
Compared against the same quarter a year earlier, not against an analyst forecast. A “beat” or “miss” needs a consensus estimate, which is licensed data we do not carry — and getting it wrong is worse than leaving it out.
OptimizeRx Corp reported on November 13, 2026. We are fetching the call transcript; its summary follows once the transcript is in.
OptimizeRx is a leading healthcare technology company that’s redefining how life science brands connect with patients and healthcare providers. Our platform combines innovative AI-driven tools like the Dynamic Audience Activation Platform (DAAP) and Micro-Neighborhood Targeting (MNT) to deliver timely, relevant, and hyper-local engagement. By bridging the gap between HCP and direct-to-consumer (DTC) strategies, we empower brands to create synchronized marketing solutions that drive faster treatment decisions and improved patient outcomes. Our commitment to privacy-safe, patient-centric technology ensures that every interaction is designed to make a meaningful impact, delivering life-changing therapies to the right patients at the right time. Headquartered in Waltham, Massachusetts, OptimizeRx partners with some of the world’s leading pharmaceutical and life sciences companies to transform the healthcare landscape and create a healthier future for all.
The company’s own description, as it appears at the foot of the release.
The quote and the company description come from OptimizeRx Corp’s Item 2.02 8-K filed November 13, 2026; the table is built from its quarterly reports. Read the release on EDGAR Share prices are split- and dividend-adjusted.
+29% y/y
Guided
—
No guide given
Full year 2026
Set against the company's own guidance and the same quarter a year earlier, not analysts' estimates, which we do not hold. Adjusted figures are the company's own non-GAAP measures, as stated in the release.